NCT03111095

Brief Summary

The purpose of this study is to see if Honeywell Genesis Android Touch Bluetooth System (mobile health) can improve patient satisfaction and quality of care provided to women experiencing complications due to high blood pressure during pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
428

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 24, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 12, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2018

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2018

Completed
6.3 years until next milestone

Results Posted

Study results publicly available

October 8, 2024

Completed
Last Updated

August 22, 2025

Status Verified

July 1, 2024

Enrollment Period

1.2 years

First QC Date

March 24, 2017

Results QC Date

November 2, 2022

Last Update Submit

August 20, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Aim 1: Number of Participants Enrolled

    A goal of 55 participants enrolled into the mobile health program was set as a feasibility target.

    up to 3 months

  • Aim 1: Number of Participants Who Completed the Study

    To assess retention, the number of participants who completed the study will be reported.

    up to 6 weeks

  • Aims 2-5: Number of Participants Enrolled in 1 Year

    Aims 2-5 primary endpoint is enrollment of up to 40 participants at all times (for a total of 42 days) over one year (220 experimental and 220 matched controls for chart review).

    up to 1 year

  • Aims 2-5: Number of Participants With Hypertension-Related Hospital Readmissions

    Comparison of hypertension-related hospital readmissions between home telehealth with remote BP monitoring group and standard outpatient care during the first 6 weeks postpartum in women with hypertensive disorders of pregnancy (HDP).

    up to 6 weeks postpartum

Secondary Outcomes (17)

  • Aim 1: 6-week Hospital Readmission

    up to 6 weeks

  • Aim 1: Number of Participants With Severe Postpartum Hypertension After Discharge

    up to 6 weeks

  • Aim 1: Number of Participants With Hypertension-Related Emergency Room Visits

    up to 6 weeks postpartum

  • Aim 1: Number of Participants With Need for Blood Pressure Treatment After Discharge

    up to 6 weeks

  • Aims 2-5: Number of Participants With Hypertension-Related Emergency Room Visits

    up to 6 weeks postpartum

  • +12 more secondary outcomes

Other Outcomes (4)

  • Cost Effective Analysis on Remote Patient Monitoring for Postpartum Hypertension.

    Up to 12 months

  • Mode of Delivery

    at delivery (on average 37-40 weeks of pregnancy)

  • Neonatal Birthweight

    at time of birth

  • +1 more other outcomes

Study Arms (2)

Mobile Health Participants

EXPERIMENTAL

Subjects will use the mobile health device to record their blood pressure and weight measurements everyday for 6 weeks postpartum.

Other: Mobile Health

Standard of Care

NO INTERVENTION

This arm is a chart review done on hypertensive women who do not participate in using the mobile health device.

Interventions

Subjects will submit blood pressure and weight measurements daily for 6 weeks postpartum. Subjects will have a video telehealth visit with the mobile health nurse at 48 hours and 7 days after discharge from the hospital.

Mobile Health Participants

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Hypertensive disorders of pregnancy including gestational, chronic, or preeclampsia diagnosed in the antenatal (primary admission for delivery of the baby (planned or due to hypertension) or postpartum period as determined by systolic blood pressure (SBP) greater than 140 or diastolic blood pressure (DBP) greater than 90 on two occasions 4 hours apart.
  • Gestational age at time of delivery greater than 23 weeks gestation
  • Postpartum with persistent SBP greater than 140 or DBP greater than 90 on two occasions 4 hours apart (to enroll would be prior to discharge from initial postpartum hospital stay).
  • Primary hospital admission for the delivery of the neonate(s).

You may not qualify if:

  • Inability to obtain informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UnityPoint Health- Meriter Hospital

Madison, Wisconsin, 53715, United States

Location

Related Publications (3)

  • Hoppe KK, Thomas N, Zernick M, Zella JB, Havighurst T, Kim K, Williams M, Niu B, Lohr A, Johnson HM. Telehealth with remote blood pressure monitoring compared with standard care for postpartum hypertension. Am J Obstet Gynecol. 2020 Oct;223(4):585-588. doi: 10.1016/j.ajog.2020.05.027. Epub 2020 May 19. No abstract available.

  • Thomas NA, Drewry A, Racine Passmore S, Assad N, Hoppe KK. Patient perceptions, opinions and satisfaction of telehealth with remote blood pressure monitoring postpartum. BMC Pregnancy Childbirth. 2021 Feb 19;21(1):153. doi: 10.1186/s12884-021-03632-9.

  • Hoppe KK, Williams M, Thomas N, Zella JB, Drewry A, Kim K, Havighurst T, Johnson HM. Telehealth with remote blood pressure monitoring for postpartum hypertension: A prospective single-cohort feasibility study. Pregnancy Hypertens. 2019 Jan;15:171-176. doi: 10.1016/j.preghy.2018.12.007. Epub 2018 Dec 31.

MeSH Terms

Conditions

Hypertension, Pregnancy-Induced

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Results Point of Contact

Title
Kara Hoppe, DO
Organization
University of Wisconsin School of Medicine and Public Health

Study Officials

  • Kara Hoppe, DO

    Clinical Assistant Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2017

First Posted

April 12, 2017

Study Start

March 23, 2017

Primary Completion

June 8, 2018

Study Completion

June 11, 2018

Last Updated

August 22, 2025

Results First Posted

October 8, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations